SARS-CoV-2 breakthrough infections among hospitalized patients in southeastern Michigan
Background: As of January 2022, more than 57 million cases of COVID-19 have been reported in the United States. Three primary COVID-19 vaccines are widely available: Pfizer (BNT162b2), Moderna (mRNA-1273), and Johnson & Johnson's-Janssen (JNJ-78436735). The vaccines are effective but do not...
Bewaard in:
Hoofdauteurs: | , , , |
---|---|
Formaat: | Boek |
Gepubliceerd in: |
Cambridge University Press,
2022-07-01T00:00:00Z.
|
Onderwerpen: | |
Online toegang: | Connect to this object online. |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Internet
Connect to this object online.3rd Floor Main Library
Plaatsingsnummer: |
A1234.567 |
---|---|
Kopie 1 | Beschikbaar |